Drug Target Review2025-12-01T08:30:13
Scientists have used human stem cell–derived kidney organoids to uncover how abnormal Hippo signalling drives scarring in nephronophthisis, a rare genetic kidney disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2023-01-20T14:24:55
Sponsored by Leica Microsystems
2023-02-13T11:57:11
Sponsored by Agilent
2023-02-03T13:56:13
Sponsored by Leica Microsystems
2026-09-30T13:00:00
Sponsored by Sartorius
2023-06-13T13:30:40
Sponsored by NanoTemper Technologies
2023-01-16T10:21:42
Sponsored by Sartorius Incucyte® Live-Cell Analysis System
Site powered by Webvision Cloud